Compounds > gabexate
Page last updated: 2024-10-27

gabexate and Blood Loss, Postoperative

gabexate has been researched along with Blood Loss, Postoperative in 2 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parodi, F1
Cordero, G1
De Gasperis, C1
Minola, P1
Dellora, C1
Innocenti, P1
Ita, M1
Okafuji, M1
Maruoka, Y1
Shinozaki, F1

Trials

1 trial available for gabexate and Blood Loss, Postoperative

ArticleYear
Gabexate mesilate, a new synthetic serine protease inhibitor: a pilot clinical trial in valvular heart surgery.
    Journal of cardiothoracic and vascular anesthesia, 1996, Volume: 10, Issue:2

    Topics: Adult; Aged; Anticoagulants; Gabexate; Heart Valve Prosthesis; Humans; Middle Aged; Pilot Projects;

1996

Other Studies

1 other study available for gabexate and Blood Loss, Postoperative

ArticleYear
An unusual postextraction hemorrhage associated with Klippel-Trenaunay-Weber syndrome.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2001, Volume: 59, Issue:2

    Topics: Adult; Anticoagulants; Dental Care for Chronically Ill; Disseminated Intravascular Coagulation; Fema

2001